A person’s genetic risk for developing a cannabis addiction is associated with structural brain differences during ...

After more than four decades, the remains of a woman who was found buried in the mountains of Riverside County, California, ...

Lipfendra is the first oral PCSK9 inhibitor approved by the FDA, giving new hope to those with high LDL cholesterol. (Adobe ...

A new generation of therapies aims to intervene at a recently discovered gap between the disease’s molecular march and its ...

Alcohol is often treated as a routine part of social life, but a new analysis suggests that even levels many Americans ...

More than a month later, Jen Schmidt remains in recovery from multiple broken bones as her case becomes the first in Lincoln to result in a citation under Nebraska’s revised ...

A combination of THC and CBD eased symptoms in an especially frail population: patients with advanced dementia near the end ...

By Artemis Molai Addiction is more likely to develop in certain brains than others. In studies reviewing families and heredity, approximately 50 to 60 percent of opioid use disorder risk is linked to ...

Using animal models representing isolated features of the disease, the team discovered that alcohol dramatically reduces ...

Summary: Researchers discovered that just a single exposure to cocaine induces profound, long-lasting structural changes inside key brain cells that persist for at least two weeks. Using advanced ...

Abraham Lincoln, for one, may have had the syndrome—and are at very high risk of a kind of fatal rupture in the heart.

Ethos Laboratories today announced the national launch of CNSDose™ , a pharmacogenomic testing platform that will be offered throughout the United States under an exclusive licensing agreement with ...